Trial Profile
A phase II trial assessing Gimsilumab
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 15 Apr 2020
Price :
$35
*
At a glance
- Drugs Gimsilumab (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 15 Apr 2020 New trial record
- 18 Mar 2020 According to a Roivant media release, the company will prioritize trials of gimsilumab in patients with COVID-19 instead of this study which was planned earlier.